A detailed history of Mirae Asset Securities (Usa) Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mirae Asset Securities (Usa) Inc. holds 25,085 shares of LLY stock, worth $18.8 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
25,085
Holding current value
$18.8 Million
% of portfolio
0.89%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $19.4 Million - $24.1 Million
25,085 New
25,085 $22.2 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mirae Asset Securities (Usa) Inc. Portfolio

Follow Mirae Asset Securities (Usa) Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Securities (Usa) Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Securities (Usa) Inc. with notifications on news.